Template Catalog

FDA Table 02
Baseline Demographic and Clinical Characteristics, Safety Population, Pooled Analyses
table
FDA
safety
demographics

FDA Table 05
Duration of Treatment Exposure, Safety Population, Pooled Analyses
table
FDA
safety
exposure

FDA Table 06
Overview of Adverse Events, Safety Population, Pooled Analyses
table
FDA
safety
adverse events

FDA Table 11
Patients with FDA Medical Query (Narrow) Leading to Treatment Discontinuation, Safety Population, Pooled Analyses
table
FDA
safety

FDA Table 12
Patients With Adverse Events Leading to Treatment Discontinuation by System Organ Class and Preferred Term, Safety Population, Pooled Analyses
table
FDA
safety

FDA Table 14
Patients With Adverse Events by System Organ Class and FDA Medical Query, Safety Population, Pooled Analyses
table
FDA
safety
adverse events

FDA Table 32
Percentage of Patients With Maximum Diastolic Blood Pressure by Category of Blood Pressure Postbaseline, Safety Population, Pooled Analysis
table
FDA
safety
vital signs

FDA Table 33
Percentage of Patients Meeting Specific Hypotension Levels Postbaseline, Safety Population, Pooled Analysis
table
FDA
safety
vital signs

FDA Table 34
Patients With Serious Adverse Events by System Organ Class, FDA Medical Query (Narrow) and Preferred Term, Safety Population, Pooled Analysis (or Trial X)
table
FDA
safety
adverse events

FDA Table 35
Patients With Adverse Events by System Organ Class, Safety Population, Pooled Analysis (or Trial X)
table
FDA
safety
adverse events

FDA Table 36
Patients With Adverse Events by System Organ Class and Preferred Term, Safety Population, Pooled Analysis (or Trial X)
table
FDA
safety
adverse events

FDA Table 38
Patients With Adverse Events by System Organ Class, FDA Medical Query (Broad) and Preferred Term, Safety Population, Pooled Analysis (or Trial X)
table
FDA
safety
adverse events
No matching items